Summary = "Inhibition of deubiquitinase (DUB) activity is often a promising strategy for cancer therapy. VLX1570 is undoubtedly an inhibitor of proteasome DUB action at the moment in scientific trials for relapsed numerous myeloma. In this article we show that VLX1570 binds to and inhibits the activity of ubiquitin-specific protease-14 https://l-ascorbic-acid14454.bloggerswise.com/27562042/myelin-oligodendrocyte-glycoprotein-peptide-35-55-mouse-rat-options